CXCR3 and type 1 diabetes mellitus: We have reported a reduction in CXCR3 on B cells in the peripheral blood of individuals with type 1 diabetes [14]; however, it is not known whether this result occurs because of a global dysregulation of this chemokine pathway under chronic autoinflammatory conditions, and whether CXCR3 B cells migrate to the pancreas.